Caly für 0,49 und keiner kauft !
12:56:32 0.600 4000 OTC BBS
12:38:19 0.596 900 OTC BBS at Bid
12:35:12 0.595 2500 OTC BBS
12:34:02 0.595 10000 OTC BBS
12:32:03 0.595 5000 OTC BBS
12:32:03 0.595 10000 OTC BBS
12:32:02 0.595 10000 OTC BBS
12:31:43 0.590 25000 OTC BBS at Bid
12:03:39 0.590 2500 OTC BBS
12:03:34 0.590 2500 OTC BBS
Traden ist für die momentane Lage gut, sehr gut sogar aber Vorsicht ist geboten...nicht vergessen Gewinne mitzunehmen (kann schnell ein Verlust draus werden).
9'000
n/a
21:59:33
0.585
14'000
n/a
21:53:55
0.59
900
n/a
21:52:52
0.59
27'500
n/a
21:52:03
0.59
2'500
n/a
21:49:41
0.59
500
n/a
21:49:38
0.59
1'000
n/a
21:48:31
0.59
2'000
n/a
21:46:56
0.6
5'000
n/a
21:43:55
0.59
2'500
n/a
21:42:18
0.59
17'500
n/a
21:41:57
0.591
10'000
n/a
21:41:29
0.591
10'000
n/a
21:41:05
0.589
1'000
n/a
21:41:01
0.595
10'000
n/a
21:41:01
0.595
10'000
n/a
21:41:01
0.595
10'000
n/a
21:41:01
0.595
100
n/a
21:40:42
0.59
2'500
n/a
21:38:18
0.59
1'000
n/a
21:30:00
0.59
100
Grüße Kade_I
Optionen
| Boardmail an "Kade_I" |
Wertpapier: Calypte Biomedical |
Produkte!!!!!!!!!!!!!!!!!!!!!!
Zulassungen!!!!!!!!!!!!!!!!!!!!
Neue schnelle billige saugeile Geldbringende Produkte!!!!!!!!!!!!!!!!!!!!!!!!!!!Produktionsstätten!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!Vertriebspartner!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
die besten Mitarbeiter von der Konkkurenz!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Cash!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!und die Marr Group!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
hab ich was vergessen ?
Europäer die sich es leisten können, Amerikaner die sich es leisten können
Krankenhäuser auf der ganzen Welt, US Army, Nato und jetzt kommen noch die ....
Russen, Chinesen, noch wer ?
Darum Eine Milliarde Dollar von der US-Regierung und andere Staaten werden und müssen folgen.
Also muß ein Schnelltest her 100 % Sicher keine Nachtests und vorallem das wichtigste überhaupt billig sein und in Massen vorhanden sein.
Sagen wir mal....
Afrika pro Jahr 50.000.000 Test a 5 $ =250.000.000 $
China pro Jahr 500.000.000 Tests a 5 $ =2.500.000.000 §
Europa und Amerika und den Rest der Welt gar nicht gerechnet.
und sollte der Test noch günstiger sein so bei 2,50$ gar nicht auszumalen wo der Kurs stehen wird.
Desweiteren muß man berechnen die ganze Welt braucht ja nicht nur einmal sondern was weiß ich 2 - 3 mal und das jedes Jahr.
MARR hat sich gut aufgestellt meine Damen und Herren und zwar mit CALY.
Eins nach dem anderen Schritt für Schritt
Nächster Schritt AMEX-Listing.
Free AIDS tests pledged in China
(Xinhua)
Updated: 2004-04-15 09:19
China offers treatment solace for sufferers
China will start providing free AIDS tests for the general public as well as free treatment for infected people who can't afford it, the government said amid stepped-up efforts to stop the spread of the virus.
China says 840,000 of its people are HIV-positive and 80,000 have full-blown AIDS. But the United Nations AIDS agency says the number of infected people in China could rise to 10 million by 2020 without more aggressive prevention efforts.
State television reported the plan for free AIDS testing on its midday national newscast. Plans for free medication and treatment were announced on the Health Ministry's Website.
The announcements didn't say how many people were expected to use the services or how much they would cost.
The ministry's announcement included a list of medications that would be provided free, but didn't give details of the income level required to qualify for them. In Beijing, government clinics offering AIDS tests has been increased from four to 22, the Beijing Daily reported.
The AIDS virus is believed to spread in China mostly through prostitution and intravenous drug use, but health officials worry that the disease could spread to the general population.
Until recently, AIDS tests were available only in centers that treated sex workers and drug addicts, but health officials now encourage them for pregnant women and some other people.
Early detection and intervention is a more effective and efficient way to prevent and control AIDS, said Ray Yip, expert with the US Center for Disease Control and Prevention.
Speaking at the press conference in Beijing on Tuesday, Yip announced that the CDC would launch a Global AIDS Program in China, cooperating with the Chinese government.
As the director of CDC-GAP China Office, Yip said GAP was launched to help countries with limited resources control the spread of the HIV virus, create a better treatment and care environment for AIDS sufferers and improve detection and intervention of possible infectious cases.
China had opened the GAP program in 10 provinces, autonomous regions and municipalities.
http://www.chinadaily.com.cn/english/doc/2004-04/15/content_323503.htm
===============================================
The CRADA between Calypte and the CDC provides for the development of a test to estimate the incident HIV infections (of less than 6 months duration) in a population survey.
The purpose of the test is to provide a simplified and rapid format that can be performed in resource poor settings and remote outreach locations as a public health surveillance tool. The test should be particularly suitable for settings with limitations in blood collection capacity, laboratory facilities, or specimen transport.
The test will be designed to provide invaluable information to Public Health agencies concerning the course of the HIV pandemic, such as identifying populations where new infections are occurring most frequently, allowing agencies to measure the effectiveness of prevention efforts in specific risk groups, and identifying high-incidence cohorts for prevention trials (e.g. microbicide, vaccine etc).
Dr. Richard George, President and CEO of Calypte commented that "A simplified and rapid format for serologic assays to estimate HIV incidence is a logical progression and refinement of the currently used, laboratory based EIA. The ability to perform tests for recent infection for public health surveillance purposes in all types of environments will dramatically expand the use and reduce the cost of incidence testing used to monitor the effectiveness of HIV prevention programs."
Optionen
| Boardmail an "Kade_I" |
Wertpapier: Calypte Biomedical |